Commercialization

Xeriant's NexBoard Achieves Top ASTM E84 Class A Fire Rating, Paving Way for Commercialization
Xeriant Inc. announced its NexBoard construction panel received the highest ASTM E84 Class A fire rating, validating years of development and expected to accelerate commercialization and convert a backlog of potential customers.

Regentis Biomaterials Advances European Commercial Launch for GelrinC with Surgeon Training Program
Regentis Biomaterials plans to start European surgeon training for its CE Mark-approved knee cartilage treatment GelrinC in Q3 2026, marking a key step toward commercialization.

American Fusion Inc. Details Commercialization Milestones for Texatron Fusion Engine Platform
American Fusion Inc. updates on prototype advancements, regulatory certification in Texas, and growing stakeholder interest, signaling progress toward commercializing its Texatron Fusion Engine.

Stonegate Capital Partners Highlights BlackSky's Gen-3 Commercialization Inflection and Upgraded Guidance
Stonegate Capital Partners updated coverage on BlackSky Technology, emphasizing accelerated Gen-3 commercialization with up to $160M in new wins, improved revenue visibility, and raised FY26 guidance.

MindBio Therapeutics Moves Toward Commercial Deployment of AI Voice Analysis for Impairment Detection in Mining Sector
MindBio Therapeutics appoints Chilean policy expert Felipe Leyton to lead commercialization of its voice-based AI platform for detecting drug and alcohol impairment, starting with South America's mining industry.

Nightfood Holdings Deploys Autonomous Robots in Live Pilot at IOA Championship
Nightfood Holdings launched a live pilot of its BIM-E and TIM-E robots at the IOA Championship, marking a critical step in commercialization and scalability for outdoor hospitality.

Burcon Nutrascience Achieves Key Commercial Milestones with Plant Protein Production and Secures Growth Financing
Burcon Nutrascience Corporation advances commercialization of its plant proteins with first commercial production and sales, while securing $4 million in financing to support growth toward profitability.

Shoulder Innovations Secures $40 Million in Financing to Advance Shoulder Surgical Care
Shoulder Innovations has closed a $40 million convertible notes financing to further commercialize its advanced implant systems for shoulder arthroplasty, aiming to improve surgical outcomes and efficiency.